Bernie Sanders Indicates Single Payer Will Eliminate Drug Companies

April 10, 2019

Sen. Bernie Sanders (I-VT) indicates that his single payer proposal eliminates drug companies during an interview with CBS News’ Ed O'Keefe. Be sure to like, subscribe, and comment below to share your thoughts on the video.

Spotlight

Hammersmith Medicines Research Ltd

HMR is a Contract Research Organisation (CRO). We specialise in and can provide a full service for phase 1 and early phase 2 studies. Our premises are spacious (5995 m²) and have 145 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. We have over 250 staff – 10 physicians, 35 nurses or nurse graduates, and over 200 graduates or PhD. We have done over 850 studies since 1993. HMR is one of the largest early-phase CROs in Europe.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

Spotlight

Hammersmith Medicines Research Ltd

HMR is a Contract Research Organisation (CRO). We specialise in and can provide a full service for phase 1 and early phase 2 studies. Our premises are spacious (5995 m²) and have 145 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. We have over 250 staff – 10 physicians, 35 nurses or nurse graduates, and over 200 graduates or PhD. We have done over 850 studies since 1993. HMR is one of the largest early-phase CROs in Europe.

Events